Hudson Edge Investment Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-380,234
Closed -$31.7M 140
2015
Q2
$31.7M Sell
380,234
-362,693
-49% -$27.6M 1.33% 47
2015
Q1
$54M Sell
742,927
-102,932
-12% -$7.33M 2.23% 10
2014
Q4
$58.4M Sell
845,859
-17,706
-2% -$1.2M 2.12% 13
2014
Q3
$56M Sell
863,565
-36,166
-4% -$2.29M 2.06% 14
2014
Q2
$55.9M Sell
899,731
-2,555
-0.3% -$152K 1.99% 15
2014
Q1
$53.1M Sell
902,286
-14,825
-2% -$827K 2.01% 15
2013
Q4
$46.8M Buy
917,111
+245,755
+37% +$12.3M 1.8% 25
2013
Q3
$33.8M Sell
671,356
-71,541
-10% -$3.75M 1.4% 41
2013
Q2
$36.5M Buy
+742,897
New +$40.4M 1.44% 40

Other funds holding LLY

Hudson Edge Investment Partners's LLY Position: Q3 2015 in Review

Hudson Edge Investment Partners sold out of Eli Lilly (LLY) in Q3 2015, closing a stake of 380,234 shares — an estimated $31.7M sold.

Hudson Edge Investment Partners first reported a position in LLY in Q2 2013 and held it in 9 quarters. The position peaked at $58.4M in Q4 2014. 1,148 funds tracked by Wall St. Rank hold LLY as of Q3 2015.

  • Hudson Edge Investment Partners reported no remaining Eli Lilly position as of Q3 2015 after selling out during the quarter.
  • Hudson Edge Investment Partners sold 380,234 Eli Lilly shares in Q3 2015, an estimated $31.7M.
  • Hudson Edge Investment Partners first reported a position in Eli Lilly in Q2 2013 and held it in 9 quarters.
  • Hudson Edge Investment Partners's Eli Lilly position peaked at $58.4M in Q4 2014.
  • 1,148 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2015.

Based on Hudson Edge Investment Partners's 13F filing for Q3 2015, filed 10 Nov 2015.